Demographics and disease characteristics by race
| Characteristic . | No. (%) . | |||
|---|---|---|---|---|
| Total . | nHW* . | API . | Other, including Hispanic . | |
| Sex | ||||
| Male | 1491 (53.9) | 1259 (52.5) | 95 (56.9) | 137 (54.8) |
| Female | 1326 (47.1) | 1141 (47.5) | 72 (43.1) | 113 (45.2) |
| Stage | ||||
| 1 | 636 (22.6) | 542 (22.6) | 17 (10.2) | 77 (30.8) |
| 2 | 1061 (37.7) | 900 (37.5) | 70 (41.9) | 91 (36.4) |
| 3 | 997 (35.4) | 844 (35.2) | 75 (44.9) | 78 (31.2) |
| Missing | 123 (4.4) | 114 (4.8) | 5 (3.0) | 4 (1.6) |
| Age, y | ||||
| Median | 71.2 | 71.6 | 68.4 | 69.1 |
| Range | 35-92 | 36-92 | 43-89 | 35-90 |
| Cytogenetics† | ||||
| Favorable | 350 (12.4) | 308 (12.8) | 8 (4.8) | 34 (13.6) |
| Adverse | 675 (24.0) | 570 (23.8) | 47 (28.1) | 58 (23.2) |
| Normal | 637 (22.6) | 548 (22.8) | 50 (29.9) | 39 (15.6) |
| Unknown | 1155 (41) | 974 (40.6) | 62 (37.1) | 119 (47.6) |
| Characteristic . | No. (%) . | |||
|---|---|---|---|---|
| Total . | nHW* . | API . | Other, including Hispanic . | |
| Sex | ||||
| Male | 1491 (53.9) | 1259 (52.5) | 95 (56.9) | 137 (54.8) |
| Female | 1326 (47.1) | 1141 (47.5) | 72 (43.1) | 113 (45.2) |
| Stage | ||||
| 1 | 636 (22.6) | 542 (22.6) | 17 (10.2) | 77 (30.8) |
| 2 | 1061 (37.7) | 900 (37.5) | 70 (41.9) | 91 (36.4) |
| 3 | 997 (35.4) | 844 (35.2) | 75 (44.9) | 78 (31.2) |
| Missing | 123 (4.4) | 114 (4.8) | 5 (3.0) | 4 (1.6) |
| Age, y | ||||
| Median | 71.2 | 71.6 | 68.4 | 69.1 |
| Range | 35-92 | 36-92 | 43-89 | 35-90 |
| Cytogenetics† | ||||
| Favorable | 350 (12.4) | 308 (12.8) | 8 (4.8) | 34 (13.6) |
| Adverse | 675 (24.0) | 570 (23.8) | 47 (28.1) | 58 (23.2) |
| Normal | 637 (22.6) | 548 (22.8) | 50 (29.9) | 39 (15.6) |
| Unknown | 1155 (41) | 974 (40.6) | 62 (37.1) | 119 (47.6) |